Medicare Enrolled

Dr. Brenda Wu

Neurology · New Brunswick, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
90 PATERSON ST, New Brunswick, NJ 08901
2019963205
In practice since 2006 (19 years)
NPI: 1255406443 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wu

Dr. Brenda Wu is a neurology specialist in New Brunswick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wu performed 793 Medicare services across 417 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wu received a total of $15,671 from 39 pharmaceutical and/or device companies across 689 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 44% volume in NJ $15,671 industry payments

Medicare Practice Summary

Medicare Utilization ↗
793
Medicare services
Top 44% in NJ for neurology
417
Unique beneficiaries
$189
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
191 $148 $365
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
105 $252 $690
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
79 $402 $1,050
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $105 $275
EEG brain wave monitoring, 41-60 minutes
This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes.
60 $315 $820
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
46 $118 $326
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
42 $31 $100
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
41 $111 $300
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
30 $196 $800
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
27 $111 $500
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
23 $79 $250
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
23 $113 $300
Video EEG monitoring, 2-12 hours
Continuous monitoring of brain wave activity combined with video recording for a duration of 2 to 12 hours.
19 $481 $1,600
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
18 $26 $200
New patient office visit, complex (60-74 min) 12 $177 $520
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,671
Total received (2018-2024)
Avg $2,239/year across 7 years
Top 20% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
689
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,091 (64.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,580 (35.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,817
2023
$7,498
2022
$2,404
2021
$1,680
2020
$961
2019
$1,035
2018
$275

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$317
Eisai Inc.
$289
Lilly USA, LLC
$260
Neurelis, Inc.
$181
ABBVIE INC.
$137
Intra-Sana Laboratories
$111
SK Life Science, Inc.
$84
Sumitomo Pharma America, Inc.
$75
PFIZER INC.
$73
CATALYST PHARMACEUTICALS, INC.
$62
Aucta Pharmaceuticals, Inc.
$56
JAZZ PHARMACEUTICALS INC.
$34
Life Molecular Imaging Ltd
$31
LivaNova USA, Inc.
$31
Lundbeck LLC
$30
Otsuka America Pharmaceutical, Inc.
$29
Marinus Pharmaceuticals, Inc.
$16
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
Catalyst Pharmaceuticals, Inc.
$5,580
UCB, Inc.
$1,548
Eisai Inc.
$1,054
Supernus Pharmaceuticals, Inc.
$815
Neurelis, Inc.
$637
SK Life Science, Inc.
$539
AbbVie Inc.
$528
Lilly USA, LLC
$515
EISAI INC.
$434
ABBVIE INC.
$433
Amgen Inc.
$431
Sunovion Pharmaceuticals Inc.
$390
AQUESTIVE THERAPEUTICS, INC.
$387
Boehringer Ingelheim Pharmaceuticals, Inc.
$250
Vanda Pharmaceuticals Inc.
$247
Lundbeck LLC
$232
Sumitomo Pharma America, Inc.
$220
PFIZER INC.
$150
Biogen, Inc.
$144
Biohaven Pharmaceuticals, Inc.
$121
Novo Nordisk Inc
$117
Intra-Sana Laboratories
$111
Biohaven Pharmaceutical Holding Company Ltd.
$110
Novartis Pharmaceuticals Corporation
$102
LivaNova USA, Inc.
$91
Aprecia Pharmaceuticals, LLC
$75
CATALYST PHARMACEUTICALS, INC.
$62
Aucta Pharmaceuticals, Inc.
$56
JAZZ PHARMACEUTICALS INC.
$50
Upsher-Smith Laboratories LLC
$45
Allergan, Inc.
$36
Life Molecular Imaging Ltd
$31
Otsuka America Pharmaceutical, Inc.
$29
Merck Sharp & Dohme LLC
$27
Marinus Pharmaceuticals, Inc.
$16
Greenwich Biosciences, Inc.
$15
OWP Pharmaceuticals, Inc.
$15
Vertical Pharmaceuticals, LLC
$13
Azurity Pharmaceuticals, Inc.
$13
Top 3 companies account for 52.2% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AMYVID · APTIOM · Aduhelm · Aimovig · BELSOMRA · BOTOX · Banzel · Briviact · COMIRNATY · Dayvigo · EMGALITY · EPIDIOLEX · Epidiolex · Eprontia · FYCOMPA · Fintepla · Fycompa · HETLIOZ · KISUNLA · Leqembi · METHYLPHENIDATE 72 · Motpoly XR · NEURACEQ · NURTEC ODT · Nayzilam · Neulasta · OFEV · OXTELLAR XR · Ozempic · QULIPTA · RELTONE 200 MG · REXULTI · SUBVENITE · SYMPAZAN · Spritam · TOPIRAMATE Extended Release Capsules · TROKENDI XR · UBRELVY · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · Vimpat · ZTALMY · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in New Brunswick?
Compare neurologists in the New Brunswick area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
294
Per 100K population
34.1
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wu is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wu experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Wu performed 191 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wu receive payments from pharmaceutical companies?
Yes. Dr. Wu received a total of $15,671 from 39 companies across 689 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wu's costs compare to other neurologists in New Brunswick?
Dr. Wu's average Medicare payment per service is $189. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →